KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Other financing activities (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Other financing activities for 9 consecutive years, with $4000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other financing activities rose 106.9% to $4000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $33000.0, a 144.59% increase, with the full-year FY2025 number at $33000.0, up 144.59% from a year prior.
  • Other financing activities was $4000.0 for Q4 2025 at Biolife Solutions, down from $9000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $145000.0 in Q3 2021 to a low of -$79000.0 in Q1 2021.
  • A 5-year average of $15736.8 and a median of $9000.0 in 2023 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: soared 1228.57% in 2021, then plummeted 1400.0% in 2023.
  • Biolife Solutions' Other financing activities stood at $145000.0 in 2021, then tumbled by 99.31% to $1000.0 in 2022, then tumbled by 1400.0% to -$13000.0 in 2023, then crashed by 346.15% to -$58000.0 in 2024, then soared by 106.9% to $4000.0 in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Other financing activities are $4000.0 (Q4 2025), $9000.0 (Q3 2025), and $10000.0 (Q2 2025).